Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04705844 |
|---|---|
| Brief Title: | Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) (COMBAAT) |
| First Submitted : | January 10, 2021 |
| First Submitted that Met QC Criteria : | January 10, 2021 |
| First Posted : | January 12, 2021 |
| Last Update Submitted that Met QC Criteria : | March 2, 2022 |
| Last Update Posted : | March 3, 2022 |